Literature DB >> 27550920

Heteromerization Between the Bradykinin B2 Receptor and the Angiotensin-(1-7) Mas Receptor: Functional Consequences.

Bruno D Cerrato1, Oscar A Carretero1, Brana Janic1, Hernán E Grecco1, Mariela M Gironacci2.   

Abstract

Bradykinin B2 receptor (B2R) and angiotensin-(1-7) Mas receptor (MasR)-mediated effects are physiologically interconnected. The molecular basis for such cross talk is unknown. It is hypothesized that the cross talk occurs at the receptor level. We investigated B2R-MasR heteromerization and the functional consequences of such interaction. B2R fused to the cyan fluorescent protein and MasR fused to the yellow fluorescent protein were transiently coexpressed in human embryonic kidney293T cells. Fluorescence resonance energy transfer analysis showed that B2R and MasR formed a constitutive heteromer, which was not modified by their agonists. B2R or MasR antagonists decreased fluorescence resonance energy transfer efficiency, suggesting that the antagonist promoted heteromer dissociation. B2R-MasR heteromerization induced an 8-fold increase in the MasR ligand-binding affinity. On agonist stimulation, the heteromer was internalized into early endosomes with a slower sequestration rate from the plasma membrane, compared with single receptors. B2R-MasR heteromerization induced a greater increase in arachidonic acid release and extracellular signal-regulated kinase phosphorylation after angiotensin-(1-7) stimulation, and this effect was blocked by the B2R antagonist. Concerning serine/threonine kinase Akt activity, a significant bradykinin-promoted activation was detected in B2R-MasR but not in B2R-expressing cells. Angiotensin-(1-7) and bradykinin elicited antiproliferative effects only in cells expressing B2R-MasR heteromers, but not in cells expressing each receptor alone. Proximity ligation assay confirmed B2R-MasR interaction in human glomerular endothelial cells supporting the interaction between both receptors in vivo. Our findings provide an explanation for the cross talk between bradykinin B2R and angiotensin-(1-7) MasR-mediated effects. B2R-MasR heteromerization induces functional changes in the receptor that may lead to long-lasting protective properties.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  B2 receptor; Mas receptor; heteromerization

Mesh:

Substances:

Year:  2016        PMID: 27550920      PMCID: PMC5016258          DOI: 10.1161/HYPERTENSIONAHA.116.07874

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  36 in total

1.  Angiotensin (1-7) induces MAS receptor internalization.

Authors:  Mariela M Gironacci; Hugo P Adamo; Gerardo Corradi; Robson A Santos; Pablo Ortiz; Oscar A Carretero
Journal:  Hypertension       Date:  2011-06-13       Impact factor: 10.190

2.  Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats.

Authors:  María A Costa; María A Lopez Verrilli; Karina A Gomez; Pablo Nakagawa; Clara Peña; Cristina Arranz; Mariela M Gironacci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-30       Impact factor: 4.733

3.  G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor.

Authors:  Evi Kostenis; Graeme Milligan; Arthur Christopoulos; Carlos F Sanchez-Ferrer; Silvia Heringer-Walther; Patrick M Sexton; Florian Gembardt; Elaine Kellett; Lene Martini; Patrick Vanderheyden; Heinz-Peter Schultheiss; Thomas Walther
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

Review 4.  International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences.

Authors:  L M Fredrik Leeb-Lundberg; Francois Marceau; Werner Müller-Esterl; Douglas J Pettibone; Bruce L Zuraw
Journal:  Pharmacol Rev       Date:  2005-03       Impact factor: 25.468

5.  Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness.

Authors:  S AbdAlla; H Lother; A el Massiery; U Quitterer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

6.  Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats.

Authors:  A Abbas; G Gorelik; L A Carbini; A G Scicli
Journal:  Hypertension       Date:  1997-08       Impact factor: 10.190

7.  Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors.

Authors:  R A Santos; M J Campagnole-Santos; N C Baracho; M A Fontes; L C Silva; L A Neves; D R Oliveira; S M Caligiorne; A R Rodrigues; C Gropen Júnior
Journal:  Brain Res Bull       Date:  1994       Impact factor: 4.077

8.  Calreticulin enhances B2 bradykinin receptor maturation and heterodimerization.

Authors:  Joshua Abd Alla; Kristin Reeck; Andreas Langer; Thomas Streichert; Ursula Quitterer
Journal:  Biochem Biophys Res Commun       Date:  2009-07-04       Impact factor: 3.575

9.  Downregulation of kinin B1 receptor function by B2 receptor heterodimerization and signaling.

Authors:  Xianming Zhang; Viktor Brovkovych; Yongkang Zhang; Fulong Tan; Randal A Skidgel
Journal:  Cell Signal       Date:  2014-10-05       Impact factor: 4.315

Review 10.  ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury.

Authors:  Jasmina Varagic; Sarfaraz Ahmad; Sayaka Nagata; Carlos M Ferrario
Journal:  Curr Hypertens Rep       Date:  2014-03       Impact factor: 5.369

View more
  12 in total

Review 1.  Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.

Authors:  Sadashiva S Karnik; Khuraijam Dhanachandra Singh; Kalyan Tirupula; Hamiyet Unal
Journal:  Br J Pharmacol       Date:  2017-03-09       Impact factor: 8.739

2.  MAS1 Receptor Trafficking Involves ERK1/2 Activation Through a β-Arrestin2-Dependent Pathway.

Authors:  Flavia M Cerniello; Oscar A Carretero; Nadia A Longo Carbajosa; Bruno D Cerrato; Robson A Santos; Hernán E Grecco; Mariela M Gironacci
Journal:  Hypertension       Date:  2017-09-05       Impact factor: 10.190

3.  Mas receptor is translocated to the nucleus upon agonist stimulation in brainstem neurons from spontaneously hypertensive rats but not normotensive rats.

Authors:  Flavia M Cerniello; Mauro G Silva; Oscar A Carretero; Mariela M Gironacci
Journal:  Cardiovasc Res       Date:  2020-10-01       Impact factor: 10.787

4.  Heteromerization fingerprints between bradykinin B2 and thromboxane TP receptors in native cells.

Authors:  Oula K Dagher; Miran A Jaffa; Aïda Habib; Fuad N Ziyadeh; Ayad A Jaffa
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

5.  Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation.

Authors:  Ingrid Lopatko Fagerström; Anne-Lie Ståhl; Maria Mossberg; Ramesh Tati; Ann-Charlotte Kristoffersson; Robin Kahn; Jean-Loup Bascands; Julie Klein; Joost P Schanstra; Mårten Segelmark; Diana Karpman
Journal:  EBioMedicine       Date:  2019-08-20       Impact factor: 8.143

6.  Peptidomics analysis revealed that a novel peptide VMP‑19 protects against Ang II‑induced injury in human umbilical vein endothelial cells.

Authors:  Zhongqing Xu; Jingjing Ding; Li Zhang; Xianzhen Feng; Jun Zhou; Xiaoyi Shen; Hong Lu; Lingmei Qian; Xun Li
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

Review 7.  A Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin-Angiotensin Systems.

Authors:  Alvin H Schmaier
Journal:  Front Med (Lausanne)       Date:  2016-11-28

Review 8.  The Vasoactive Mas Receptor in Essential Hypertension.

Authors:  Amalie L Povlsen; Daniela Grimm; Markus Wehland; Manfred Infanger; Marcus Krüger
Journal:  J Clin Med       Date:  2020-01-18       Impact factor: 4.241

9.  Angiotensin AT1 and AT2 receptor heteromer expression in the hemilesioned rat model of Parkinson's disease that increases with levodopa-induced dyskinesia.

Authors:  Rafael Rivas-Santisteban; Ana I Rodriguez-Perez; Ana Muñoz; Irene Reyes-Resina; José Luis Labandeira-García; Gemma Navarro; Rafael Franco
Journal:  J Neuroinflammation       Date:  2020-08-17       Impact factor: 8.322

Review 10.  The Meaning of Mas.

Authors:  Michael Bader; Natalia Alenina; Dallan Young; Robson A S Santos; Rhian M Touyz
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.